A novel combretastatin A-4 derivative, AC7700, strongly stanches tumour blood flow and inhibits growth of tumours developing in various tissues and organs

British Journal of Cancer

Volumn 86, Issue 10, 2002, Pages 1604-1614

  Hori, K ^a   Saito, S ^a   Kubota, K ^a  

^a TOHOKU UNIVERSITY   (Japan)

Author keywords

Combretastatin A 4; Metastasis; Microcirculation; Tumour blood flow; Tumour vessel

Indexed keywords

COMBRETASTATIN A4; SERINE 2 METHOXY 5 [2 (3,4,5 TRIMETHOXYPHENYL)VINYL]ANILIDE;

ADOLESCENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CHEMOTHERAPY; CANCER INHIBITION; CONTROLLED STUDY; DRUG EFFECT; EXPERIMENTAL NEOPLASM; HUMAN; HUMAN CELL; KIDNEY TUMOR; LIVER TUMOR; LYMPHOMA; MALE; METASTASIS; MICROCIRCULATION; MUSCLE TUMOR; NONHUMAN; PRIORITY JOURNAL; RAT; STOMACH TUMOR; TUMOR BLOOD FLOW;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CARCINOMA; DRUG SCREENING ASSAYS, ANTITUMOR; HEART NEOPLASMS; KIDNEY NEOPLASMS; LIVER NEOPLASMS, EXPERIMENTAL; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; NEOPLASM TRANSPLANTATION; ORGAN SPECIFICITY; PRODRUGS; RATS; REGIONAL BLOOD FLOW; SARCOMA, YOSHIDA; SERINE; SKIN WINDOW TECHNIQUE; STOMACH NEOPLASMS; TUMOR CELLS, CULTURED; VASOCONSTRICTOR AGENTS;

EID: 0037141466     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6600296     Document Type: Article

References (37)

1. Vascular reaction of normal and malignant tissues in vivo. VI. The role of hypotension in the action of components of podophyllin on transplantable sarcomas
2. Measurement of local blood flow with hydrogen gas
3. Inhibition of growth of colon 38 adenocarcinoma by vinblastine and colchicine: Evidence for a vascular mechanism
4. Reduction of tumor blood flow by flavone acetic acid: A possible component of therapy
5. Antivascular approaches to solid tumour therapy: Evaluation of tubulin binding agents
6. Anti-vascular approaches to solid tumour therapy: Evaluation of combretastatin A4 phosphate
7. Induction of tumor necrosis factor-α messenger RNA in human and murine cells by the flavone acetic acid analogue 5,6 -dimethylxanthenone-4-acetic acid (NSC 640488)
8. Combretastatin A-4, an agent that displays potent and selective toxicity toward tumor vasculature
9. Vascular occlusion and tumour cell death
10. Tumor angiogenesis: Therapeutic implications
11. In vivo and in vitro evaluation of combretastatin A-4 and its sodium phosphate prodrug
12. Novel B-ring modified combretastatin analogues: Syntheses and antineoplastic activity
13. Vascular collapse after flavone acetic acid: A possible mechanism of its anti-tumour action
14. Vinca alkaloids: Antivascular effects in a murine tumour
15. Antivascular effects of vinflunine in the MAC 15A transplantable adenocarcinoma model
16. A model of lymph node metastasis by transplantation of tumor cells into rat ear
17. In vivo analysis of tumor vascularization in the rat
18. Fluctuations in tumor blood flow under normotension and the effect of angiotensin II-induced hypertension
19. Variation of growth rate of a rat tumour during a light-dark cycle: Correlation with circadian fluctuations in tumour blood flow
20. Timing of cancer chemotherapy based on circadian variations in tumor tissue blood flow
21. Antitumor effects due to irreversible stoppage of tumor tissue blood flow: Evaluation of a novel combretastatin A-4 derivative, AC7700
22. Stoppage of blood flow in 3-methyl-cholanthrene-induced autochthonous primary tumor due to a novel combretastatin A-4 derivative, AC7700, and its antitumor effect
23. The effect of combretastatin A-4 disodium phosphate in a C3H mouse mammary carcinoma and a variety of murine spontaneous tumors
24. Tumor angiogenesis: Past, present and the near future
25. The vasculature of xenotransplanted human melanomas and sarcomas on nude mice. II. Scanning and transmission electron microscopic studies
26. Vascular targeting of solid tumours: A major 'inverse' volume-response relationship following combretastatin A-4 phosphate treatment of rat rhabdomyosarcomas
27. Angiogenesis: Regulators and clinical applications
28. Evaluation of antivascular and antimitotic effects of tubulin binding agents in solid tumor therapy
29. A novel combretastatin A-4 derivative, AC-7700, shows marked antitumor activity against advanced solid tumors and orthotopically transplanted tumors
30. Novel combretastatin analogues effective against murine solid tumors: Design and structure-activity relationships
31. Syntheses and antitumor activity of cis-restricted combretastatins: 5-Membered heterocyclic analogues
32. Structural and functional characteristics of the microcirculation in neoplasms
33. Isolation and structure of the strong cell growth and tubulin inhibitor combretastatin A-4
34. Ultrastructure of the microvascular wall: Functional correlations
35. Combretastatin A-4 phosphate as a tumor vascular-targeting agent: Early effects in tumors and normal tissues
36. United Kingdom Co-ordinating Committee on Cancer Research (UKCCCR) guidelines for the welfare of animals in experimental neoplasia (second edition)
37. Blood flow failure as a major determinant in the antitumor action of flavone acetic acid